Alfa Cytology can detect specific sequence changes in DNA
isolated from brain tumor patient samples (e.g., peripheral blood
extracellular vesicles from glioma patients) to identify potential
biological markers. RNAs (including miRNAs and lncRNAs) obtained
from peripheral blood or body fluid exosomes are more abundant and
tumor-specific. Therefore, we looked for proteins that were highly
expressed by observing the expression profiles of exosomal miRNA
and lncRNA in brain tumors (glioblastoma) compared with normal
tissues as biological markers for the diagnosis of glioblastoma.
Alfa Cytology provides services on
exosome for brain tumors.
.